GPR49基因对肝癌细胞增殖侵袭能力的影响

汤凯雯; 唐云强; 龚远锋; 赵宏宇; 王嘉康; 唐辉; 麦聪

doi:10.3969/j.issn.1674-7445.2015.03.005

GPR49基因对肝癌细胞增殖侵袭能力的影响

doi: 10.3969/j.issn.1674-7445.2015.03.005

广州医科大学附属肿瘤医院腹外二科(汤凯雯、唐云强、龚远锋、赵宏宇、王嘉康、唐辉、麦聪)，妇瘤科(汤凯雯)

基金项目:

广东省医学科研基金 B2012170

广州市医药卫生科技项目 20121A011168

详细信息

通讯作者:
麦聪, Email:maicong2010@126.com

中图分类号: R617
计量
- 文章访问数: 76
- HTML全文浏览量: 12
- PDF下载量: 4
- 被引次数: 0
出版历程
- 收稿日期: 2015-01-30
- 网络出版日期: 2021-01-19
- 刊出日期: 2015-05-15

Effect of GPR49 gene on proliferation and invasive ability of hepatoma cells

Department of the Second Abdominal Surgery, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou 510095, China

More Information

Corresponding author: Mai Cong, Email:maicong2010@126.com

摘要

摘要: 目的探讨肝癌细胞系Huh7细胞中G蛋白偶联受体49(GPR49)基因对肝癌细胞侵袭能力的影响及其分子生物学机制。方法根据转染的小干扰RNA(si-RNA)不同, 将Huh7细胞分为GPR49-siRNA(si-GPR49)组和阴性对照NC-siRNA(si-NC)组, 另设未转染Huh7细胞为对照组(control组)。采用逆转录聚合酶链反应(RT-PCR)法和Western blot法分别检测3组细胞GPR49、细胞周期素D1(cyclin D1)、基质金属蛋白酶9(MMP9)的信使核糖核酸(mRNA)和蛋白的表达。采用MTT法和Transwell法分别检测各组细胞增殖能力和侵袭能力。结果 si-GPR49组GPR49 mRNA的相对表达量为control组的(23.8±3.1)%(P < 0.05)。与control组相比, si-GPR49组GPR49、cyclin D1、MMP9蛋白的表达量均明显降低(均为P < 0.05)。MTT检测细胞增殖能力实验结果显示, si-GPR49组细胞在72 h的吸光度(OD)值(0.53±0.12)明显低于control组(1.35±0.28), 差异有统计学意义(P < 0.05)。si-GPR49组平均穿膜细胞数为(13.6±2.5)个, 明显低于control组的(65.3±6.1)个, 差异有统计学意义(P < 0.05)。结论 GPR49-siRNA可抑制Huh7细胞GPR49基因表达。其机制可能是通过降低cyclin D1水平抑制Huh7细胞的增殖能力, 通过影响MMP9蛋白表达水平抑制Huh7细胞的迁移和侵袭能力。
- 原发性肝癌 /
- 核糖核酸干扰 /
- Huh7细胞 /
- G蛋白偶联受体49 /
- 细胞周期素D1 /
- 基质金属蛋白酶9
Abstract: Objective To discuss the effect of G-protein-coupled receptor 49 (GPR49) gene on proliferation and invasive ability of hepatoma cell line Huh7 and its molecular biological mechanism. Methods According to the different transfected small interfering RNA(si-RNA), Huh7 cells were divided into the GPR49-siRNA(si-GPR49)group and the NC-siRNA (si-NC) group. Untransfected Huh7 cells were set as the control group. Messenger RNA(mRNA)and protein expression of GPR49, cyclin D1 and matrix metalloproteinase 9 (MMP9) in the cells of the three groups were respectively detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot method. The proliferation and invasive ability of the cells of each group were respectively detected by MTT method and Transwell method. Results The relative expression of GPR49 mRNA of the si-GPR49 group was (23.8±3.1)% of the control group (P < 0.05). Compared with the control group, the protein expression of GPR49, cyclin D1 and MMP9 of the si-GPR49 group decreased significantly(all in P < 0.05). The proliferation experiment results by MTT indicated that the optical density(OD)of the cells of the si-GPR49 group at 72 h was (0.53±0.12), which was significantly lower than that of the control group(1.35±0.28). The difference had statistical significance (P < 0.05). The average invaded cell counts of the si-GPR49 group were (13.6±2.5), which was significantly lower than (65.3±6.1) of the control group. The difference had statistical significance (P < 0.05). Conclusions GPR49-siRNA may inhibit the gene expression of GPR49 in Huh7 cells. Its mechanism may be that the proliferation of Huh7 cells is inhibited by reducing the level of cyclin D1; the migration and invasive ability of Huh7 cells is inhibited by affecting the expression level of MMP9.
- Primary hepatocellular carcinoma /
- Ribonucleic acid interference /
- Huh7 cells /
- G-protein-coupled receptor 49 /
- Cyclin D1 /
- Matrix metalloproteinase 9

HTML全文

图 1 3组Huh7细胞GPR49 mRNA表达的比较

注：与control组比较，^aP＜0.05

Figure 1. Comparison of expression levels of GPR49 mRNA of Huh7 cells among the three groups

下载: 全尺寸图片幻灯片

图 2 3组Huh7细胞GPR49、cyclin D1、MMP9的蛋白表达

注：与control组比较，^aP＜0.05

Figure 2. Comparison of expression of GPR49, cyclin D1 and MMP9 protein of Huh7 cells among the three groups

下载: 全尺寸图片幻灯片

参考文献(18)

[1]	Eng OS, Tsang AT, Moore D, et al. Outcomes of microwave ablation for colorectal cancer liver metastases:a single center experience[J]. J Surg Oncol, 2014, DOI: 10.1002/jso.23849.
[2]	Llovet JM. Liver cancer:time to evolve trial design after everolimus failure[J]. Nat Rev Clin Oncol, 2014, 11(9):506-507. doi: 10.1038/nrclinonc.2014.136
[3]	Huang Y, Yang X, Zhao F, et al. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence[J]. Med Oncol, 2014, 31(7):966. doi: 10.1007/s12032-014-0966-8
[4]	Ge Y, Ding Y, Zhang J, et al. Effect of angiogenesis inhibitor SU6668 in combination with 5-Fu on liver metastasis from transplantation tumors of human colorectal cancer in nude mice[J]. Int J Clin Exp Med, 2014, 7(10):3578-3582. http://cn.bing.com/academic/profile?id=1452664954&encoded=0&v=paper_preview&mkt=zh-cn
[5]	Pu X, Guo QX, Long HA, et al. Effects of mTOR-STAT3 on the migration and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer[J]. Asian Pac J Trop Med, 2014, 7(5):368-372. doi: 10.1016/S1995-7645(14)60057-2
[6]	Tanese K, Fukuma M, Yamada T, et al. G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation[J]. Am J Pathol, 2008, 173(3):835-843. doi: 10.2353/ajpath.2008.071091
[7]	Rot S, Taubert H, Bache M, et al. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients[J]. BMC Cancer, 2011, 11:429. doi: 10.1186/1471-2407-11-429
[8]	Guo Y, Chen W, Wang W, et al. Simultaneous diagnosis and gene therapy of immuno-rejection in rat allogeneic heart transplantation model using a T-cell-targeted theranostic nanosystem[J]. ACS Nano, 2012, 6(12):10646-10657. doi: 10.1021/nn3037573
[9]	Shen WW, Zeng Z, Zhu WX, et al. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells[J]. J Mol Med, 2013, 91(8):989-1000. doi: 10.1007/s00109-013-1037-x
[10]	Guo Y, Liang X, Lu M, et al. Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma[J]. Hepatogastroenterology, 2010, 57(101):913-918. https://www.ncbi.nlm.nih.gov/pubmed/21033251
[11]	Ye X, Guo Y, Zhang Q, et al. βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/cyclin D1 signaling pathway[J]. PLoS One, 2013, 8(1):e55615. doi: 10.1371/journal.pone.0055615
[12]	Chen Q, Cao HZ, Zheng PS. LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway[J]. Oncotarget, 2014, 5(19):9092-9105. doi: 10.18632/oncotarget
[13]	da Silva-Diz V, Solé-Sánchez S, Valdés-Gutiérrez A, et al. Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis[J]. Oncogene, 2013, 32(32):3732-3743. doi: 10.1038/onc.2012.375
[14]	Fafilek B, Krausova M, Vojtechova M, et al. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells[J]. Gastroenterology, 2013, 144(2):381-391. doi: 10.1053/j.gastro.2012.10.048
[15]	Gao FJ, Chen JY, Wu HY, et al. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer[J]. Int J Clin Exp Pathol, 2014, 7(4):1572-1579. http://cn.bing.com/academic/profile?id=291580039&encoded=0&v=paper_preview&mkt=zh-cn
[16]	Kobayashi S, Yamada-Okabe H, Suzuki M, et al. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution[J]. Stem Cells, 2012, 30(12):2631-2644. doi: 10.1002/stem.v30.12
[17]	Spengler RM, Oakley CK, Davidson BL. Functional microRNAs and target sites are created by lineage-specific transposition[J]. Hum Mol Genet, 2014, 23(7):1783-1793. doi: 10.1093/hmg/ddt569
[18]	Zhou MK, Liu XJ, Zhao ZG, et al. MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells[J]. Mol Med Rep, 2015, 11(4):2947-2952. doi: 10.3892/mmr.2014.3052/download